Thank you.
I'm picking up on that point. Clinical trials are something that we've been addressing extensively during these hearings.
Can you tell me—succinctly, please, if you would be so kind, because I'd like to split my time with Mr. Young—what you feel are the key elements to ensuring that there is transparency for patients and consumers across Canada.